Swine Flu Boosts Tamiflu Sales by 203pct: Roche

by VR Sreeraman on  July 23, 2009 at 5:56 PM Drug News   - G J E 4
Sales of anti-flu drug Tamiflu soared 203 percent in the first six months of 2009, Swiss pharmaceutical giant Roche said Thursday, contributing to a 9.0 percent growth in overall sales for the group.
 Swine Flu Boosts Tamiflu Sales by 203pct: Roche
Swine Flu Boosts Tamiflu Sales by 203pct: Roche

Amid the swine flu pandemic, sales of the drug reached 1.0 billion Swiss francs (938 million dollars or 659 million euros) in the first half of the year.

Sales to governments and corporations which were stockpiling the drug reached 653 million francs during the period, said Roche.

"Additional government stockpiling orders and increased demand in the retail pharmacy market contributed to the particularly strong sales recorded in the second quarter," it added.

Roche said it would be ramping up its production capacity of Tamiflu -- one of two drugs recommended by the World Health Organisation to treat the A(H1N1) virus -- to 400 million packs annually by 2010.

In its first half earnings statement, the group also said that overall sales reached 24 billion Swiss francs, up 9 percent.

Net profit was however down 29 percent to 4.1 billion Swiss francs due to charges related to the acquisition of Genentech.

Source: AFP

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like